From a CRO serving big Pharma Companies locally, we have grown to a specialty full-service CRO serving small, medium and big sponsors globally.

We thank our investigators, employees and sponsors who are a part of this successful journey and invite you to join us into an exciting future.
We have successfully conducted:
> 1300 Ph I-IV studies with
> 180,000 patients at
> 13,500 sites in the world leading to
> 200 marketing authorization in six continents.

Although we provide clinical research services to six out of top ten global pharma, the major portion of our service we render to small, medium pharma and biotech companies.

We contribute to drug development in :
  • Diagnostic contrast imaging agents including radio-labelled drugs.
  • Cell therapy, bringing to market allogenic drugs and devices.
  • Biosimilars where we have conducted more than ten biosimilar studies.
  • Affordable and accessible generics.
  We offer clinical development services to pharmaceutical, biotechnology, generic, regenerative medicine, nutritional, device and medical diagnostics industries.

Our service quality, therapeutic expertise and global reach have allowed us to grow steadily, bringing value to our clients. We provide an attractive package of services coupled with the ability to rapidly conduct clinical trials utilizing a world class delivery platform.

Our long company history, wide geographic presence, extensive patient access, regulatory credibility, quality standards as well as the cultural diversity and capabilities of our team enhance our client benefits.
Oct 27-29, 2014
Meet us at 3rd OMICS Group International's Conference on Biosimilars, Hyderabad. Join Dr. Shabana's talk on 'Potential value of Biosimilars' on Oct 27.
Add event »
February 17-18, 2015
Meet us at CTIP, Munich
Add event »
Career Openings
Clinical Research in India –Stakeholder Roundtable anchored by Dr. Kher
'What should the New Indian Govt. do in Clinical Research' by D A Prasanna, Chairman ACRO India
  Disclaimer | Privacy Policy | Site Map